CDSCO introduces SHRESTH index to improve performance of state drug regulatory authorities: Shardul Nautiyal, Mumbai Saturday ...

A milestone for Indian medtech, NIT Rourkela-developed StopBleed receives regulatory approval: Our Bureau, Chennai Friday, ...

China NMPA accepts for priority review GSK’s NDA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Friday, February 27, 2026, 14: ...

US FDA accepts Vanda Pharmaceuticals’ BLA for imsidolimab to treat Generalized Pustular Psoriasis: Washington Friday, February 27, 2026, 17:00 Hrs [IST] Vanda Pharmaceuticals In ...

IDEAYA Biosciences begins patient enrolment in phase 1 trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC: South San Francisco, California Friday, February 27, 2026 ...

Lupin Ranks No. 1 globally in pharma; Tops all sectors in India in S&P ESG Assessment 2025: Our Bureau, Mumbai Friday, February 27, 2026, 11:30 Hrs [IST] Global pharma major Lupin ...

START appoints Dr Frank Smith as president of its XenoSTART preclinical research business unit: San Antonio, Texas Friday, February 27, 2026, 14:30 Hrs [IST] The START Center for ...

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that the full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc ...

Our Bureau, Mumbai Friday, February 27, 2026, 13:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has ...

Asahi Kasei Pharma strengthens preclinical pipeline through exclusive global license pact with Alchemedicine for novel lead compounds: Tokyo Friday, February 27, 2026, 11:00 Hrs [ ...

Mevion Medical Systems’ MEVION S250-FIT Proton Therapy System receives European Union CE marking: Littleton, Massachusetts Friday, February 27, 2026, 16:00 Hrs [IST] Mevion Medi ...

Our Bureau, Chennai Friday, February 27, 2026, 12:15 Hrs [IST] ...